Pfizer, Anumana team up to develop AI algorithm for cardiac amyloidosis detection

Under the multi-year strategic partnership, Anumana will conduct a clinical validation trial and seek FDA De Novo classification for the algorithm.

from MobiHealthNews https://ift.tt/2aAOE0M
https://ift.tt/krva7Up